27
7
8
3a
8
4f
16
c
f
19
1
49
2
8
8
28
11
1b
1d
18
79
35
1d
2 29
1d
25
35
Justin E. Bekelman, M.D.
4bMarietta and Howard Stoeckel Professor
7
69
Department: Radiation Oncology
4
1
b
1d
46
Contact information
4e
4
3
3
1d
4e
Department of Radiation Oncology
1e Abramson Cancer Center
23 Perelman School of Medicine
22 University of Pennsylvania
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
1e Abramson Cancer Center
23 Perelman School of Medicine
22 University of Pennsylvania
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
30
Office: (215) 662-7266
34 Fax: (215) 349-8975
24
f
34 Fax: (215) 349-8975
24
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 A.B. 41 (Princeton School of Public and International Affairs) c
3c Princeton University, Princeton, NJ, 1995.
21 9 M.D. c
4a Yale University School of Medicine, New Haven, CT, 2003.
c
3
27
21 9 A.B. 41 (Princeton School of Public and International Affairs) c
3c Princeton University, Princeton, NJ, 1995.
21 9 M.D. c
4a Yale University School of Medicine, New Haven, CT, 2003.
c
Links
a2 Search PubMed for articles
86 Penn Center for Cancer Care Innovation at the Abramson Cancer Center
c
5
3
3
92
Permanent linka2 Search PubMed for articles
86 Penn Center for Cancer Care Innovation at the Abramson Cancer Center
c
2 29
21
1e
1d
24
63
68
e 29
27
Description of Content-based Expertise
b2 Cancer Health Services Research, Clinical Epidemiology, Patient-Oriented Research, Clinical Trials, Innovation, Health and Behavioral Economics, and Public Policy68
Description of Methodology Expertise
b2 Cancer Health Services Research, Clinical Epidemiology, Patient-Oriented Research, Clinical Trials, Innovation, Health and Behavioral Economics, and Public Policye 29
23
9f Bekelman JE and Lee WR: 6 Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer 4b Int J Radiat Oncol Biol Phys 97(4): 718-721, 2017.
e9 Ojerholm E, Halpern SD, Bekelman JE: Default options: opportunities to improve quality and value in oncology. Journal of Clinical Oncology 34(16): 1844-7, 2016.
1c0 Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ: Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA 315(3): 272-283, 2016.
139 Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer. Journal of Clinical Oncology 33(7): 716-22, 2015.
129 Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE: Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncology 1(7): 897-906, 2015.
15a Bekelman JE, Sylwestrzak G, Barron J, Liu J, Epstein AJ, Freedman G, Malin J, Emanuel EJ: Uptake and Costs of Hypofractionated vs. Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008 - 2013. JAMA 312(23): 2542-50, December 2014.
b9 Bekelman JE, Kim M, Emanuel EJ: Toward Accountable Cancer Care. JAMA Internal Medicine 173(11): 958-9, Jun 2013.
e1 Bekelman JE, Epstein AJ, Emanuel EJ: Single vs Multiple Fraction Radiotherapy for Bone Metastases from Prostate Cancer. JAMA 310(14): 1501-02, Oct 2013.
2c
7
1d
1f
Selected Publications
10b Yasaitis L, Polsky D*, Bekelman J*: Relation between Narrow Networks and Providers of Cancer Care. Journal of Clinical Oncology 35(27): 3131-3135, 2017 Notes: *Denotes equal author contribution.9f Bekelman JE and Lee WR: 6 Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer 4b Int J Radiat Oncol Biol Phys 97(4): 718-721, 2017.
e9 Ojerholm E, Halpern SD, Bekelman JE: Default options: opportunities to improve quality and value in oncology. Journal of Clinical Oncology 34(16): 1844-7, 2016.
1c0 Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ: Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA 315(3): 272-283, 2016.
139 Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer. Journal of Clinical Oncology 33(7): 716-22, 2015.
129 Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE: Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncology 1(7): 897-906, 2015.
15a Bekelman JE, Sylwestrzak G, Barron J, Liu J, Epstein AJ, Freedman G, Malin J, Emanuel EJ: Uptake and Costs of Hypofractionated vs. Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008 - 2013. JAMA 312(23): 2542-50, December 2014.
b9 Bekelman JE, Kim M, Emanuel EJ: Toward Accountable Cancer Care. JAMA Internal Medicine 173(11): 958-9, Jun 2013.
e1 Bekelman JE, Epstein AJ, Emanuel EJ: Single vs Multiple Fraction Radiotherapy for Bone Metastases from Prostate Cancer. JAMA 310(14): 1501-02, Oct 2013.
2c